Prescription Antibiotic Tablets Recalled Due to Temperature Abuse
McKesson Medical-Surgical is recalling Sulfamethoxazole and Trimethoprim Tablets (800mg/160mg) nationwide due to cGMP deviations caused by temperature abuse during manufacturing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a prescription antibiotic due to cGMP deviations from temperature abuse. No adverse health consequences have been reported. The recall is classified as High because it involves a risk-of-harm scenario (potential drug instability) in the absence of reported injuries.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Sulfamethoxazole and Trimethoprim Tablets, USP (800mg/160mg), a prescription antibiotic, distributed nationwide. The recall was initiated due to cGMP deviations that resulted from temperature abuse during manufacturing.
No adverse health consequences have been reported in association with this recall.
Patients currently taking this medication should contact their healthcare provider or pharmacist regarding whether their supply may be affected. Healthcare providers and pharmacies should consult the distribution dates provided in McKesson's recall notification letters to determine whether they received affected product.
The recalled product
- Product
- SULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM)
- Brand
- SULFAMETHOXAZOLE AND TRIMETHOPRIM
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Prescription Antibiotic
- Hazard
- temperature-abuse
- manufacturing-defect
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SULFAMETHOXAZOLE AND TRIMETHOPRIM
- ModeratePrescription Antibiotic Tablets Recalled for Packaging Material Contamination
FDA (Drugs) · 2025-09-24
- ModerateAntibiotic Drug Tablets Recalled Due to Microbial Contamination in Packaging
FDA (Drugs) · 2025-09-17
- HighFDA Recalls Antibiotic Drug Sulfamethoxazole and Trimethoprim for Packaging Contamination
FDA (Drugs) · 2025-09-17
- ModeratePrescription antibiotic tablets recalled due to packaging contamination
FDA (Drugs) · 2025-09-10
- SevereAntibiotic Tablets Recalled Nationwide for Microbial Contamination
FDA (Drugs) · 2025-06-18
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27